The case of a 56-year-old woman, with a previous history of systemic lupus erythematosus (SLE), later diagnosed as also affected by active dermatomyositis (DM) associated with tuberculosis (TB) is reported. Since TB is a contra-indication to receive immunosuppressive therapy for DM/SLE, intravenous immunoglobulins (IVIG) with tow-dose steroids and anti-TB therapy were administered with excellent clinical results. This report underlines the crucial role of IVIG in the treatment of critical patients suffering from connective tissue disorders associated with severe infections. (C) 2007 Elsevier Inc. All rights reserved
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
SummaryThe incidences of infection with Mycobacterium tuberculosis and Cryptococcus neoformans in im...
A 26-year-old woman was diagnosed with and treated for systemic lupus erythematosus (SLE) in 2002. S...
We aimed to investigate the efficacy and safety profile of high-dose intravenous immunoglobulin (HD-...
The authors describe the case of a 49 years old female with a progressive tetraparesis with two year...
BackgroundTreatment of a multi-drug resistant tuberculosis (MDR-TB) patient is clinically challengin...
55-year-old African female with a history of initially refractory TIF1-y antibody positive dermatomy...
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology, which can affect a...
Discoid lupus erythematosus (DLE) is a chronic dermatological disease that can lead to scarring, alo...
© Copyright Clinical and Experimental Rheumatology 2022.Shrinking lung syndrome is a rare manifestat...
Drug-Induced Lupus is an autoimmune disorder (DIL) sharing similarity with Systemic Lupus Erythemato...
Tuberculosis is one of the top 10 causes of death worldwide according to the World Health Organizati...
antiphospholipid syndrome, intrave-nous immunoglobulin, lupus, ulcer J Dermatol Case Rep 2014 2, pp ...
Improved strength and functional abilities following IV immunoglobulin treatment for chronic dermato...
The clinical use of intravenous immunoglobulin (IVIg) has expanded beyond its traditional place in t...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
SummaryThe incidences of infection with Mycobacterium tuberculosis and Cryptococcus neoformans in im...
A 26-year-old woman was diagnosed with and treated for systemic lupus erythematosus (SLE) in 2002. S...
We aimed to investigate the efficacy and safety profile of high-dose intravenous immunoglobulin (HD-...
The authors describe the case of a 49 years old female with a progressive tetraparesis with two year...
BackgroundTreatment of a multi-drug resistant tuberculosis (MDR-TB) patient is clinically challengin...
55-year-old African female with a history of initially refractory TIF1-y antibody positive dermatomy...
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology, which can affect a...
Discoid lupus erythematosus (DLE) is a chronic dermatological disease that can lead to scarring, alo...
© Copyright Clinical and Experimental Rheumatology 2022.Shrinking lung syndrome is a rare manifestat...
Drug-Induced Lupus is an autoimmune disorder (DIL) sharing similarity with Systemic Lupus Erythemato...
Tuberculosis is one of the top 10 causes of death worldwide according to the World Health Organizati...
antiphospholipid syndrome, intrave-nous immunoglobulin, lupus, ulcer J Dermatol Case Rep 2014 2, pp ...
Improved strength and functional abilities following IV immunoglobulin treatment for chronic dermato...
The clinical use of intravenous immunoglobulin (IVIg) has expanded beyond its traditional place in t...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
SummaryThe incidences of infection with Mycobacterium tuberculosis and Cryptococcus neoformans in im...
A 26-year-old woman was diagnosed with and treated for systemic lupus erythematosus (SLE) in 2002. S...